Lazard may snare Medibank Private mandate
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
Lazard Ltd may be in prime position to win the mandate to conduct the potential sale of Medibank Private, perhaps the first large-scale privatisation by the Abbott government.
Joe Hockey, now the Treasurer, said in 2010 the sale of Medibank Private could raise up to $4.5 billion. Medibank Private has reportedly had annual operating profits of about $200 million, most of which has been paid as dividends to the government.
The Howard government hired Carnegie Wylie to undertake two scoping studies of the health insurer in 2003 and 2006. Carnegie Wylie was acquired by Lazard in 2007, around the time then Prime Minister John Howard decided not to proceed with the sale of Medibank Private.
Another scoping study will have to be conducted on Medibank Private and that may settle on a potential valuation of the asset. The government will then have to decide whether to sell it to a buyer or conduct an initial public offering.
Lazard is currently advising the New Zealand government on the IPO of Meridian Energy Ltd. after earlier this year advising it on the IPO of Mighty River Power Ltd.
The firm is currently ranked number two on the Australian merger and acquisition league tables, according to Bloomberg data. It has a 12 per cent market share having worked on eight deals worth $6.91 billion.
Call 1300 880 160
Start a chat
Schedule a call
